By addressing hunger signals, the therapy helps individuals maintain healthier eating patterns and reduce overeating
Protect against moisture and light
This may include people who: Are early in treatment Recently changed their dose Already have nausea, vomiting, reflux, diarrhea, or constipation Have trouble staying hydrated Have diabetes or take blood sugar-lowering medication Have a history of pancreatitis Have gallbladder disease or gallstones Have liver disease or abnormal liver enzymes Drink heavily or binge drink Have a history of alcohol use disorder Are pregnant, trying to become pregnant, or breastfeeding Are taking other medications that interact with alcohol If any of these apply to you, do not guess
They are GLP-1 receptor agonists, which mimic the action of a natural hormone in the body to help control hunger, slow gastric emptying, and improve insulin sensitivity
Plasma metabolomic markers of insulin resistance and diabetes and rate of incident Parkinsons disease